Skip to Main Content

Paper Details

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
Lancet Neurol
87
2018
CI 046-, CSF, FTLD, FTLD-TDP type A, GFRA2, GFRA2 locus, GFRA2 mRNA, GRN, GRN mutation, GRN mutations, HEK293T cells, Neurological Disorders, Patients, Stroke, TAR DNA-binding protein 43, TDP-43, TMEM106B, cerebellar tissue samples, chromosome 8p21, frontotemporal lobar degeneration, genetic variants, genome-wide significant variants, mRNA, neurodegenerative diseases, neurodegenerative disorders, patients, progranulin, risk-associated allele, rs1990622, rs36196656
Author NameAffiliation
Gregory D JenkinsMayo Clinic
Daniel J SerieMayo Clinic
NiCole A FinchMayo Clinic
Elizabeth FingerSchulich School of Medicine and Dentistry, University of Western Ontario
Peter HeutinkHertie-Institute for Clinical Brain Research and Center for Neurology, Germany German Center for Neurodegenerative Diseases (DZNE)
Leonard PetrucelliMayo Clinic
Oscar L LopezUniversity of Pittsburgh
Eric M ReimanBanner Alzheimer's Institute
Marwan N SabbaghBarrow Neurological Institute, University of Arizona College of Medicine Phoenix, Creighton University School of Medicine
Anna KarydasUniversity of California san francisco
Adam L BoxerUniversity of California san francisco
M-Marsel MesulamNorthwestern University
John Q TrojanowskiPerelman School of Medicine, Center for Neurodegenerative Disease Research, University of Pennsylvania
Nil??fer Ertekin-TanerMayo Clinic
David S KnopmanMayo Clinic
Sandra E BlackUniversity of Toronto and Sunnybrook Health Sciences Centre, Sunnybrook Research Institute
Jean-Paul G VonsattelTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center
Lawrence S HonigTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center
Juliane WinkelmannInstitute of Neurogenomics, Neurologische Klinik und Poliklinik und Institut fur Humangenetik, Technical University of Munich
Daniela GalimbertiUniversity of Milan, Fondazione Ca' Granda, IRCCS Ospedale Policlinico
Safa Al-SarrajDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, King's College London, NHS Foundation Trust
Nigel J CairnsKnight Alzheimer Disease Research Center, Washington University School of Medicine
Ging-Yuek R HsiungUniversity of British Columbia
Ronald C PetersenMayo Clinic
William W SeeleyUniversity of California san francisco
Bruce L MillerUniversity of California san francisco
Neill R Graff-RadfordMayo Clinic
Bradley F BoeveMayo Clinic
Dennis W DicksonMayo Clinic
Joanna M BiernackaMayo Clinic
Rosa RademakersMayo Clinic
  • 1 - 31

Datasets